NASDAQ:ADAP - Adaptimmune Therapeutics Price Target & Analyst Ratings

Sign in or create an account to add this stock to your watchlist.
$5.16 -0.20 (-3.73 %)
(As of 12/14/2018 04:00 PM ET)
Previous Close$5.16
Today's Range$5.10 - $5.3850
52-Week Range$4.82 - $14.63
Volume371,966 shs
Average Volume560,685 shs
Market Capitalization$506.07 million
P/E Ratio-6.45
Dividend YieldN/A
Beta2.01

Analyst Ratings

Adaptimmune Therapeutics (NASDAQ:ADAP) Price Target and Consensus Rating

  (How are Consensus Ratings Calculated?)
5 Wall Street analysts have issued ratings and price targets for Adaptimmune Therapeutics in the last 12 months. Their average twelve-month price target is $16.00, suggesting that the stock has a possible upside of 210.08%. The high price target for ADAP is $20.00 and the low price target for ADAP is $12.00. There are currently 5 buy ratings for the stock, resulting in a consensus rating of "Buy."
Today30 Days Ago90 Days Ago180 Days Ago
Consensus Rating: BuyBuyBuyBuy
Consensus Rating Score: 3.003.003.003.00
Ratings Breakdown: 0 Sell Rating(s)
0 Hold Rating(s)
5 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
0 Hold Rating(s)
5 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
0 Hold Rating(s)
4 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
0 Hold Rating(s)
4 Buy Rating(s)
0 Strong Buy Rating(s)
Consensus Price Target: $16.00$18.00$19.3333$19.3333
Price Target Upside: 210.08% upside175.65% upside125.59% upside50.81% upside

Adaptimmune Therapeutics (NASDAQ:ADAP) Consensus Price Target History

Price Target History for Adaptimmune Therapeutics (NASDAQ:ADAP)

Adaptimmune Therapeutics (NASDAQ:ADAP) Analyst Ratings History

Show:
DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails
12/13/2018SunTrust BanksLower Price TargetBuy$12.00MediumView Rating Details
11/6/2018CowenReiterated RatingBuyMediumView Rating Details
10/22/2018Raymond JamesLower Price TargetOutperform ➝ Buy$20.00 ➝ $16.00HighView Rating Details
9/17/2018GuggenheimInitiated CoverageBuyHighView Rating Details
6/4/2018Leerink SwannBoost Price TargetOutperform$20.00HighView Rating Details
3/17/2017Wells Fargo & CoInitiated CoverageMarket Perform ➝ Market PerformLowView Rating Details
(Data available from 12/15/2016 forward)
This page was last updated on 12/15/2018 by MarketBeat.com Staff

Featured Article: How Short Selling Works

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel